Camp4 Therapeutics Corporation
CAMP
$4.10
$0.164.06%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 74.48% | 31.60% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 74.48% | 31.60% | |||
| Cost of Revenue | 1.94% | 1.50% | |||
| Gross Profit | 4.76% | 0.60% | |||
| SG&A Expenses | 9.71% | -18.72% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 4.06% | -4.96% | |||
| Operating Income | 0.55% | 6.66% | |||
| Income Before Tax | -1.24% | 6.37% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -1.24% | 6.37% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -1.24% | 6.37% | |||
| EBIT | 0.55% | 6.66% | |||
| EBITDA | 0.64% | 6.88% | |||
| EPS Basic | -1.22% | 19.86% | |||
| Normalized Basic EPS | -1.19% | 19.85% | |||
| EPS Diluted | -1.22% | 19.86% | |||
| Normalized Diluted EPS | -1.19% | 19.85% | |||
| Average Basic Shares Outstanding | 0.03% | 16.83% | |||
| Average Diluted Shares Outstanding | 0.03% | 16.83% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||